This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Actinium Pharmaceuticals, Limited. Active years: 2012-2017.
Location History:
- Ismaning, DE (2012)
- Ostermudigen, CH (2017)
- Ostermundigen, CH (2017)
Company Filing History:
Years Active: 2012-2017
Title: **Andreas Turler: A Pioneer in Radiochemical Innovations**
Introduction
Andreas Turler is an accomplished inventor based in Ostermudigen, Switzerland. He has made significant contributions to the field of radiochemistry, particularly through his innovative methods of purification. With a total of three patents to his name, Turler's work has important implications for pharmaceutical applications.
Latest Patents
Among his noteworthy inventions, Turler has two recent patents related to the purification of Actinium-225 (Ac-225) from irradiated Radium-226 (Ra-226) targets. The first patent describes a comprehensive method involving a leaching treatment of Ra-226 targets using nitric or hydrochloric acid, which enables the leaching of almost the entire content of Ac and Ra. This process is followed by two extraction chromatography steps: the first separates Ac from Ra and other Ra isotopes, while the second separates Ac from Polonium (Po) and Lead (Pb). The purified Ac-225 can be utilized to prepare compositions that are beneficial for pharmaceutical purposes.
Career Highlights
Andreas Turler is currently affiliated with Actinium Pharmaceuticals, Limited, where he applies his expertise in radiochemical processes. His role in the company allows him to further explore and refine his innovative purification methods, contributing to advancements in therapeutic applications.
Collaborations
Throughout his career, Turler has collaborated with esteemed colleagues such as Josue Manuel Moreno Bermudez and Richard Henkelmann. These collaborations have facilitated the exchange of ideas and knowledge, leading to the development of cutting-edge technologies in radiochemistry.
Conclusion
Andreas Turler's work represents a significant stride in the field of radiopharmaceuticals. His innovative methods for the purification of Ac-225 not only enhance the efficiency of obtaining this key isotope but also open new avenues for its application in medicine. With his ongoing contributions and collaborations, Turler is poised to make even further impacts in the domain of radiochemical research.